Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells

Nature Medicine

Volumn 7, Issue 10, 2001, Pages 1118-1122

  Gorelink, L ^a   Flavell, R A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR ANTIGEN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CONTROL; CELL GROWTH; CELL TRANSFER; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY; TUMOR IMMUNOLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 0034770605     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1001-1118     Document Type: Article

References (25)

1. + T cell-mediated immunity
2. Enhancement of antitumor immunity by CTLA-4 blockade
3. Regulation of immune responses by TGF-β
4. Role of transforming growth factor β in cancer
5. Transforming growth factor β secretion from primary breast cancer fibroblasts
6. +) T cells established from murine tumor-infiltrating lymphocytes
7. Depletion of IL-10- and TGF-β-producing regulatory γ δ T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells
8. Expression and secretion of TGF-β isoforms and expression of TGF-β-receptors I, II and III in normal and neoplastic human breast
9. TGF-β contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice
10. Pregnancy ameliorates induction and expression of experimental autoimmune uveitis
11. Abrogation of TGF-β signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
12. Interleukin-2 suppresses activated macrophage intracellular killing activity by inducing macrophages to secrete TGF-β
13. +) cytotoxic T lymphocytes
14. The central role of CD4(+) T cells in the antitumor immune response
15. RAG-1-deficient mice have no mature B and T lymphocytes
16. Introduction of soluble protein into the class I pathway of antigen processing and presentation
17. A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations
18. Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells
19. Prostate cancer in a transgenic mouse
20. + T cell- and IL-2-dependent mechanism
21. In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance
22. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation
23. Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation
24. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor β (TGF-β) production by murine CD4(+) T cells
25. Insight into the mechanism(s) through which TNF promotes the generation of T cell-mediated antitumor cytotoxicity by tumor bearer splenic cells